Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61654 | 1.00 | TSHR (0.32) | TSHRCYP2C19 | |
| SCHEMBL60474 | 1.00 | TSHR (0.32) | TSHRCYP2C19 | |
| Hydrochloric Acid SCHEMBL9009933 | 0.97 | TSHR (0.31) | TSHRCYP2C19 | |
| SCHEMBL61974 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL3168559 | 0.95 | — | — | |
| SCHEMBL61735 | 0.92 | — | — | |
| SCHEMBL61083 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL8681308 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL5960763 | 0.81 | — | — | |
| SCHEMBL4441457 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 531 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122239-A1 | DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE | HOLST BIRGITTE (DK) | 2025-04-17 | — | — | US | claimed |
| WO-2025069009-A1 | ROCK2 INHIBITORS IN THE TREATMENT OF OBESITY | GRAVITON BIOSCIENCE BV (NL) | 2025-04-03 | — | — | WO | claimed |
| CN-119119207-A | Phase separated polypeptide and GLP-1 RAs derivative containing same | 北京化工大学 | 2024-12-13 | — | — | CN | claimed |
| CN-118994411-A | High-stability long-acting GLP-1 RAs derivative | 北京化工大学 | 2024-11-22 | — | — | CN | claimed |
| EP-3891176-B1 | DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE | HOLST BIRGITTE (DK) | 2024-06-05 | — | — | EP | claimed |
| CN-117778530-A | Method for adding preset joint to 5' end of single-stranded DNA | 清华大学 | 2024-03-29 | — | — | CN | claimed |
| EP-3250191-B1 | TABLETS COMPRISING GLP-1 AGONIST AND ENTERIC COATING | NOVO NORDISK AS (DK) | 2024-01-17 | — | — | EP | claimed |
| EP-2637698-B1 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | NOVO NORDISK AS (DK) | 2022-04-20 | — | — | EP | claimed |
| US-20220056077-A1 | DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE | RATNER, Cecilia (DK) | 2022-02-24 | — | — | US | claimed |
| CN-107205948-B | Tablets comprising a GLP-1 agonist and an enteric coating | 诺和诺德股份有限公司 | 2021-12-14 | — | — | CN | claimed |
| WO-2006097537-A2 | ACYLATED GLP-1 COMPOUNDS | NOVO NORDISK A/S (DK) | 2006-09-21 | — | — | WO | claimed |
| EP-1696962-A2 | NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS | NOVO NORDISK A/S (DK) | 2006-09-06 | — | — | EP | claimed |
| WO-2006087354-A2 | INSULINOTROPIC AGENTS CONJUGATED WITH STRUCTURALLY WELL DEFINED BRANCHED POLYMERS | NOVO NORDISK A/S (DK) | 2006-08-24 | — | — | WO | claimed |
| EP-1670515-A2 | ALBUMIN-BINDING DERIVATIVES OF THERAPEUTIC PEPTIDES | NOVO NORDISK A/S (DK) | 2006-06-21 | — | — | EP | claimed |
| EP-1667724-A2 | ALBUMIN-BINDING DERIVATIVES OF THERAPEUTIC PEPTIDES | NOVO NORDISK A/S (DK) | 2006-06-14 | — | — | EP | claimed |
| WO-2006037810-A2 | PROTRACTED GLP-1 COMPOUNDS | NOVO NORDISK A/S (DK) | 2006-04-13 | — | — | WO | claimed |
| WO-2005058954-A1 | NOVEL GLP-1 COMPOUNDS | NOVO NORDISK A/S (DK) | 2005-06-30 | — | — | WO | claimed |
| WO-2005058958-A2 | NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS | NOVO NORDISK A/S (DK) | 2005-06-30 | — | — | WO | claimed |
| WO-2005028516-A2 | ALBUMIN-BINDING DERIVATIVES OF THERAPEUTIC PEPTIDES | NOVO NORDISK A/S (DK) | 2005-03-31 | — | — | WO | claimed |
| WO-2005027978-A2 | ALBUMIN-BINDING DERIVATIVES OF THERAPEUTIC PEPTIDES | NOVO NORDISK A/S (DK) | 2005-03-31 | — | — | WO | claimed |